Subacute Cutaneous Lupus Erythematosus (SCLE) is a rare and chronic skin disorder that affects approximately 1 in 250,000 people. It is a type of autoimmune disorder, meaning that the body’s immune system mistakenly attacks healthy tissue. SCLE is a type of lupus, a group of diseases that can affect any part of the body, including the skin, joints, and organs. While the exact cause of SCLE is unknown, it is believed to be triggered by certain environmental factors, such as exposure to sunlight, certain medications, and infections. SCLE is characterized by a rash that usually appears on the upper body, neck, and arms. The rash is typically red, scaly, and may be accompanied by itching.
Subacute Cutaneous Lupus Erythematosus (SCLE) is a chronic, autoimmune skin disorder that is characterized by a rash on the upper body, neck, and arms. The rash typically appears as red, scaly patches and may be accompanied by itching. SCLE is considered to be a type of lupus, a group of diseases that can affect any part of the body, including the skin, joints, and organs. SCLE is believed to be triggered by certain environmental factors, such as exposure to sunlight, certain medications, and infections.
The most common symptom of SCLE is a rash on the upper body, neck, and arms. The rash typically appears as red, scaly patches and may be accompanied by itching. Other symptoms of SCLE may include: • Fatigue • Joint pain • Muscle aches • Fever • Hair loss • Mouth sores • Photosensitivity
SCLE can be difficult to diagnose because its symptoms can be similar to other skin conditions. To diagnose SCLE, doctors will typically take a medical history and conduct a physical exam. The doctor may also order blood tests to look for antibodies associated with lupus. In some cases, a skin biopsy may be necessary to confirm the diagnosis.
The primary goal of treatment for SCLE is to reduce inflammation and relieve symptoms. Treatment may include topical or oral medications, such as corticosteroids, antimalarials, and immunosuppressants. In some cases, phototherapy may also be recommended.
The exact cause of SCLE is unknown, so it is not possible to prevent the condition. However, there are some steps that can be taken to reduce the risk of flare-ups. These include avoiding direct sunlight, wearing protective clothing, and using sunscreen with an SPF of at least 30. Additionally, people with SCLE should avoid certain medications and infections that may trigger a flare-up.
Living with SCLE can be difficult, but there are ways to manage the condition and reduce the risk of flare-ups. It is important to follow the treatment plan prescribed by your doctor and to take steps to protect your skin from the sun. Additionally, it is important to take care of your mental health by engaging in activities that you enjoy and seeking support from family and friends.
Subacute Cutaneous Lupus Erythematosus (SCLE) is a rare and chronic skin disorder that affects approximately 1 in 250,000 people. It is a type of autoimmune disorder, meaning that the body’s immune system mistakenly attacks healthy tissue. The exact cause of SCLE is unknown, but it is believed to be triggered by certain environmental factors. SCLE is characterized by a rash that usually appears on the upper body, neck, and arms. Treatment for SCLE may include medications, phototherapy, and lifestyle changes. While there is no known cure for SCLE, it is possible to manage the condition and reduce the risk of flare-ups.
1.
Prostate cancer Q&A: Improving detection and reducing overtreatment
2.
FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting
3.
A retrospective study examined the role of CA 19-9 and CEA in duodenal adenocarcinoma prognosis.
4.
Polatuzumab Vedotin Boosts Survival in Relapsed DLBCL
5.
New imaging technique identifies glioblastoma patients who would benefit from immunotherapy
1.
Understanding Villous Adenoma: Causes, Symptoms, and Treatments
2.
Unlocking the Potential of Leukemia Treatment: A New Hope for Patients
3.
Generative AI for Adaptive Oncology Trial Design
4.
The Future is Now: Navigating the Precision Revolution in Oncology Treatment
5.
Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
From Guidelines to Practice: Hematology
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part II
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation